Cardio-Selective Beta-Blocker: Pharmacological Evidence and Their Influence on Exercise Capacity

The selectivity of β-adrenoceptor agonists at human β1-, β2- and β3-adrenoceptors

(2010) Jillian G Baker   BRITISH JOURNAL OF PHARMACOLOGY

Are there functional β3-adrenoceptors in the human heart?

(2010) Martin C Michel et al.   BRITISH JOURNAL OF PHARMACOLOGY

Myocardial  -adrenoceptor down-regulation early after infarction is associated with long-term incidence of congestive heart failure

(2010) O. Gaemperli et al.   EUROPEAN HEART JOURNAL

Exercise intolerance in chronic heart failure: mechanisms and therapies. Part I

(2010) Massimo F. Piepoli et al.   EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION

Nebivolol Lowers Blood Pressure and Increases Weight Loss in Patients With Hypertension and Diabetes in Regard to Age

(2010) Dennis Ladage et al.   JOURNAL OF CARDIOVASCULAR PHARMACOLOGY

Isoform-Specific Increases in Murine Skeletal Muscle Peroxisome Proliferator-Activated Receptor-γ Coactivator-1α (PGC-1α) mRNA in Response to β2-Adrenergic Receptor Activation and Exercise

(2008) Shinji Miura et al.   ENDOCRINOLOGY

β-Adrenergic Blockade and Metabo-Chemoreflex Contributions to ExerciseCapacity

(2008) SOFIA BELOKA et al.   MEDICINE AND SCIENCE IN SPORTS AND EXERCISE

Major differences in gene expression in human coronary smooth muscle cells after nebivolol or metoprolol treatment

(2007) Sabine C. Wolf et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY